BetaStem Therapeutics, Inc. , a pre-clinical biotechnology company focused on a curative treatment for diabetic retinopathy and diseases related to vascular damage , has retained Conditas Biotechnology Group, LLC for its services in the area of business development and corporate strategy.
http://www.freshnews.com/news/822800/betastem-therapeutics-retains-conditas-biotechnology-group-business-development-and-cor
http://www.freshnews.com/news/822800/betastem-therapeutics-retains-conditas-biotechnology-group-business-development-and-cor
No comments:
Post a Comment